| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 5,680 | $30 | $192.9K |
| J0717 | Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 39,400 | $1 | $157.6K |
| J1602 | Injection, golimumab, 1 mg, for intravenous use | 13,250 | $10 | $145.8K |
| Q5104 | Injection, infliximab-abda, biosimilar, (renflexis), 10 mg | 2,240 | $30 | $62.7K |
| J0897 | Injection, denosumab, 1 mg | 1,920 | $20 | $36.5K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 220 | $100 | $22.6K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 290 | $80 | $21.4K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 170 | $130 | $21.2K |
| 96401 | The provider administers nonhormonal, antineoplastic chemotherapy drugs subcutaneously or intramuscularly to the patient. | 260 | $70 | $18K |
| 96365 | The provider administers the initial intravenous infusion of a medication or other substance for a period up to one hour to prevent, treat, or diagnose a condition or disease. | 160 | $60 | $10K |